US 11377444
Pyridopyrimidine compounds acting as mTORC 1/2 dual inhibitors
granted A61PA61P35/00
Quick answer
US patent 11377444 (Pyridopyrimidine compounds acting as mTORC 1/2 dual inhibitors) held by Medshine Discovery Inc. expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Medshine Discovery Inc.
- Grant date
- Tue Jul 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P35/00